Adjuvant Treatment of Elderly Breast Cancer Patients: Offer the Best Chances of Cure

https://doi.org/10.2217/fon.13.120

2.

Markopoulos

C

,

van de Water

W

,

van de Velde

CJ

.

Breast cancer in the elderly: reducing the losses

.

Future Oncol

.

2013

Sep

;

9

(

9

):

1253

–

6

.

[PubMed]

1479-6694

https://doi.org/10.1007/s10549-016-3787-y

3.

Bergen

ES

,

Tichy

C

,

Berghoff

AS

,

Rudas

M

,

Dubsky

P

,

Bago-Horvath

Z

, et al.

Prognostic impact of breast cancer subtypes in elderly patients

.

Breast Cancer Res Treat

.

2016

May

;

157

(

1

):

91

–

9

.

[PubMed]

0167-6806

https://doi.org/10.3322/caac.21590

4.

Siegel

RL

,

Miller

KD

,

Jemal

A

.

Cancer statistics, 2020

.

CA Cancer J Clin

.

2020

Jan

;

70

(

1

):

7

–

30

.

[PubMed]

0007-9235

https://doi.org/10.3322/caac.21583

5.

DeSantis

CE

,

Ma

J

,

Gaudet

MM

,

Newman

LA

,

Miller

KD

,

Goding Sauer

A

, et al.

Breast cancer statistics, 2019

.

CA Cancer J Clin

.

2019

Nov

;

69

(

6

):

438

–

51

.

[PubMed]

0007-9235

https://doi.org/10.1016/j.cger.2011.10.002

6.

Noone

AM

,

Howlader

N

,

Krapcho

M

,

Miller

D

,

Brest

A

,

Yu

M

, et al. CK (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site,

April

2018

.

7.

VanderWalde

A

,

Hurria

A

.

Early breast cancer in the older woman

.

Clin Geriatr Med

.

2012

Feb

;

28

(

1

):

73

–

91

.

[PubMed]

0749-0690

8.

Smith‐Graziani

D

,

Lei

X

,

Giordano

SH

,

Zhao

H

,

Karuturi

M

,

Chavez‐MacGregor

M

.

Delayed initiation of adjuvant chemotherapy in older women with breast cancer.

Cancer Med.

2020

Aug

;cam4.3363.

https://doi.org/10.1200/JCO.2003.02.046

9.

Bouchardy

C

,

Rapiti

E

,

Fioretta

G

,

Laissue

P

,

Neyroud-Caspar

I

,

Schäfer

P

, et al.

Undertreatment strongly decreases prognosis of breast cancer in elderly women

.

J Clin Oncol

.

2003

Oct

;

21

(

19

):

3580

–

7

.

[PubMed]

0732-183X

https://doi.org/10.1016/j.amjsurg.2005.07.028

10.

Truong

PT

,

Bernstein

V

,

Lesperance

M

,

Speers

CH

,

Olivotto

IA

.

Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer

.

Am J Surg

.

2006

Jun

;

191

(

6

):

749

–

55

.

[PubMed]

0002-9610

https://doi.org/10.1056/NEJM199912303412706

11.

Hutchins

LF

,

Unger

JM

,

Crowley

JJ

,

Coltman

CA

Jr,

Albain

KS

.

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

.

N Engl J Med

.

1999

Dec

;

341

(

27

):

2061

–

7

.

[PubMed]

0028-4793

https://doi.org/10.1097/AOG.0000000000002158

12.

Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women

.

Obstet Gynecol

.

2017

Jul

;

130

(

1

):

e1

–

16

.

[PubMed]

0029-7844

https://doi.org/10.1001/jama.2015.13183

13.

Myers

ER

,

Moorman

P

,

Gierisch

JM

,

Havrilesky

LJ

,

Grimm

LJ

,

Ghate

S

, et al.

Benefits and harms of breast cancer screening: A systematic review. JAMA -

.

JAMA

.

2015

Oct

;

314

(

15

):

1615

–

34

.

[PubMed]

0098-7484

https://doi.org/10.7326/M15-2886

14.

Siu

AL

;

U.S. Preventive Services Task Force

.

Screening for breast cancer: U.S. Preventive services task force recommendation statement

.

Ann Intern Med

.

2016

Feb

;

164

(

4

):

279

–

96

.

[PubMed]

0003-4819

15.

Network

NCC

. NCCN Guidelines Version 1.

Breast Cancer Screening and Diagnosis [Internet]

.

2015

;

2014

:

24

–

34

. [cited 2020 Apr 8].

https://doi.org/10.1001/jama.2015.12783

16.

Oeffinger

KC

,

Fontham

ET

,

Etzioni

R

,

Herzig

A

,

Michaelson

JS

,

Shih

YC

, et al.;

American Cancer Society

.

Breast cancer screening for women at average risk: 2015 Guideline update from the American cancer society. JAMA -

.

JAMA

.

2015

Oct

;

314

(

15

):

1599

–

614

.

[PubMed]

0098-7484

https://doi.org/10.2147/CIA.S65304

17.

Braithwaite

D

,

Demb

J

,

Henderson

LM

.

Optimal breast cancer screening strategies for older women: current perspectives

.

Clin Interv Aging

.

2016

Feb

;

11

:

111

–

25

.

[PubMed]

1176-9092

https://doi.org/10.1001/jamaoncol.2017.0482

18.

Lee

CS

,

Sengupta

D

,

Bhargavan-Chatfield

M

,

Sickles

EA

,

Burnside

ES

,

Zuley

ML

.

Association of patient age with outcomes of current-era, large-scale screening mammography: analysis of data from the national mammography database

.

JAMA Oncol

.

2017

Aug

;

3

(

8

):

1134

–

6

.

[PubMed]

2374-2437

https://doi.org/10.1200/JOP.2014.003517

19.

Guerard

EJ

,

Deal

AM

,

Williams

GR

,

Jolly

TA

,

Nyrop

KA

,

Muss

HB

.

Falls in Older Adults With Cancer: Evaluation by Oncology Providers

.

J Oncol Pract

.

2015

Nov

;

11

(

6

):

470

–

4

.

[PubMed]

1554-7477

https://doi.org/10.1002/14651858.CD006211.pub3

20.

Ellis

G

,

Gardner

M

,

Tsiachristas

A

,

Langhorne

P

,

Burke

O

,

Harwood

RH

, et al.

Comprehensive geriatric assessment for older adults admitted to hospital

.

Cochrane Database Syst Rev

.

2017

Sep

;

9

(

9

):

CD006211

.

[PubMed]

1469-493X

https://doi.org/10.1016/S1470-2045(11)70383-7

21.

Rubenstein LZ, Stuck AE, Siu AL, Wieland D. Impacts of Geriatric Evaluation and Management Programs on Defined Outcomes: Overview of the Evidence. J Am Geriatr Soc. 1991 Sep;39(9 Pt 2):8S–16S; discussion 17S–18S.

22.

Biganzoli

L

,

Wildiers

H

,

Oakman

C

,

Marotti

L

,

Loibl

S

,

Kunkler

I

, et al.

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

.

Lancet Oncol

.

2012

Apr

;

13

(

4

):

e148

–

60

.

[PubMed]

1470-2045

https://doi.org/10.1016/j.critrevonc.2006.04.003

23.

Overcash

JA

,

Beckstead

J

,

Moody

L

,

Extermann

M

,

Cobb

S

.

The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation

.

Crit Rev Oncol Hematol

.

2006

Sep

;

59

(

3

):

205

–

10

.

[PubMed]

1040-8428

24.

Barber

JH

,

Wallis

JB

,

McKeating

E

.

A postal screening questionnaire in preventive geriatric care

.

J R Coll Gen Pract

.

1980

Jan

;

30

(

210

):

49

–

51

.

[PubMed]

0035-8797

25.

Fried

LP

,

Tangen

CM

,

Walston

J

,

Newman

AB

,

Hirsch

C

,

Gottdiener

J

, et al.

Frailty in Older Adults: Evidence for a Phenotype. Journals Gerontol Ser A Biol Sci

.

Med Sci

.

2001

Mar

;

56

(

3

):

M146

–

57

.0096-6800

https://doi.org/10.1111/j.1532-5415.2009.02497.x

26.

Min

L

,

Yoon

W

,

Mariano

J

,

Wenger

NS

,

Elliott

MN

,

Kamberg

C

, et al.

The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients

.

J Am Geriatr Soc

.

2009

Nov

;

57

(

11

):

2070

–

6

.

[PubMed]

0002-8614

https://doi.org/10.3747/co.26.4869

27.

NCCN

.

NCCN Clinical Practice Guidelines in Oncology Older Adult Oncology.

2020

Available from: https://www.nccn.org/professionals/physician_gls/pdf/senior.pdf

28.

Mariano

C

,

Jamal

R

,

Bains

P

,

Hejazi

S

,

Chao

L

,

Wan

J

, et al.

Utility of a chemotherapy toxicity prediction tool for older patients in a community setting

.

Curr Oncol

.

2019

Aug

;

26

(

4

):

234

–

9

.

[PubMed]

1198-0052

https://doi.org/10.1200/jco.2010.28.15_suppl.9000

29.

Extermann

M

,

Boler

I

,

Reich

R

,

Lyman

GH

,

Brown

RH

,

DeFelice

J

, et al.

The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: design and validation

.

J Clin Oncol

.

2010

May

;

28

(

15

suppl

):

9000

–

9000

.

0732-183X

https://doi.org/10.1016/j.ejso.2015.01.027

30.

Cortadellas

T

,

Córdoba

O

,

Gascón

A

,

Haladjian

C

,

Bernabeu

A

,

Alcalde

A

, et al.

Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution

.

Eur J Surg Oncol

.

2015

May

;

41

(

5

):

635

–

40

.

[PubMed]

0748-7983

https://doi.org/10.1016/j.ejso.2017.01.012

31.

Morgan

JL

,

Walters

SJ

,

Collins

K

,

Robinson

TG

,

Cheung

KL

,

Audisio

R

, et al.

What influences healthcare professionals’ treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment

.

Eur J Surg Oncol

.

2017

Jul

;

43

(

7

):

1282

–

7

.

[PubMed]

0748-7983

https://doi.org/10.1016/j.ejso.2017.02.006

32.

Hamelinck

VC

,

Stiggelbout

AM

,

van de Velde

CJ

,

Liefers

GJ

,

Bastiaannet

E

.

Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists

.

Eur J Surg Oncol

.

2017

Jul

;

43

(

7

):

1288

–

96

.

[PubMed]

0748-7983

https://doi.org/10.3238/arztebl.2015.0577

33.

Peters

E

,

Anzeneder

T

,

Jackisch

C

,

Dimpfl

T

,

Kunz

G

,

Katalinic

A

, et al.

The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy.

Dtsch Aerzteblatt Online.

2015

Aug

DOI:

https://doi.org/10.1089/jwh.2015.5639

34.

LeMasters

TJ

,

Madhavan

SS

,

Sambamoorthi

U

,

Vyas

AM

.

Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer: A Population-Based Study

.

J Womens Health (Larchmt)

.

2017

Jul

;

26

(

7

):

735

–

44

.

[PubMed]

1540-9996

https://doi.org/10.1159/000480087

35.

Gal

O

,

Ishai

Y

,

Sulkes

A

,

Shochat

T

,

Yerushalmi

R

.

Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome

.

Oncology

.

2018

;

94

(

1

):

31

–

8

.

[PubMed]

0030-2414

https://doi.org/10.1016/j.bjps.2016.06.003

36.

Hamnett

KE

,

Subramanian

A

.

Breast reconstruction in older patients: A literature review of the decision-making process

.

J Plast Reconstr Aesthet Surg

.

2016

Oct

;

69

(

10

):

1325

–

34

.

[PubMed]

1748-6815

https://doi.org/10.1016/j.amjsurg.2017.07.036

37.

Chagpar

AB

,

Horowitz

N

,

Sanft

T

,

Wilson

LD

,

Silber

A

,

Killelea

B

, et al.

Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?

Am J Surg

.

2017

Dec

;

214

(

6

):

1082

–

8

.

[PubMed]

0002-9610

https://doi.org/10.1016/j.jgo.2016.12.003

38.

Liang

S

,

Hallet

J

,

Simpson

JS

,

Tricco

AC

,

Scheer

AS

.

Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis

.

J Geriatr Oncol

.

2017

Mar

;

8

(

2

):

140

–

7

.

[PubMed]

1879-4068

https://doi.org/10.1016/j.amjsurg.2015.11.005

39.

Kantor

O

,

Pesce

C

,

Liederbach

E

,

Wang

CH

,

Winchester

DJ

,

Yao

K

.

Surgery and hormone therapy trends in octogenarians with invasive breast cancer

.

Am J Surg

.

2016

Mar

;

211

(

3

):

541

–

5

.

[PubMed]

0002-9610

https://doi.org/10.1016/j.ejso.2015.05.022

40.

Morgan

JL

,

Collins

K

,

Robinson

TG

,

Cheung

KL

,

Audisio

R

,

Reed

MW

, et al.

Healthcare professionals’ preferences for surgery or primary endocrine therapy to treat older women with operable breast cancer

.

Eur J Surg Oncol

.

2015

Sep

;

41

(

9

):

1234

–

42

.

[PubMed]

0748-7983

https://doi.org/10.2217/fon.15.13

41.

Johnston

SJ

,

Cheung

KL

.

The role of primary endocrine therapy in older women with operable breast cancer

.

Future Oncol

.

2015

;

11

(

10

):

1555

–

65

.

[PubMed]

1479-6694

https://doi.org/10.1007/s10549-015-3455-7

42.

Cheung

WY

,

Lai

EC

,

Ruan

JY

,

Chang

JT

,

Setoguchi

S

.

Comparative adherence to oral hormonal agents in older women with breast cancer

.

Breast Cancer Res Treat

.

2015

Jul

;

152

(

2

):

419

–

27

.

[PubMed]

0167-6806

https://doi.org/10.1093/jnci/djx141

43.

Goldvaser

H

,

Barnes

TA

,

Šeruga

B

,

Cescon

DW

,

Ocaña

A

,

Ribnikar

D

, et al.

Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: A systematic review and meta-analysis

.

J Natl Cancer Inst

.

2018

Jan

;

110

(

1

):

31

–

9

.

[PubMed]

0027-8874

https://doi.org/10.1016/j.amjsurg.2018.07.052

44.

Wazir

U

,

Mokbel

L

,

Wazir

A

,

Mokbel

K

.

Optimizing adjuvant endocrine therapy for early ER+ breast cancer: an update for surgeons

.

Am J Surg

.

2019

Jan

;

217

(

1

):

152

–

5

.

[PubMed]

0002-9610

https://doi.org/10.1016/j.ctrv.2018.06.015

45.

McGee

SF

,

Mazzarello

S

,

Caudrelier

JM

,

Lima

MA

,

Hutton

B

,

Sienkiewicz

M

, et al.

Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer - A systematic review

.

Cancer Treat Rev

.

2018

Sep

;

69

:

132

–

42

.

[PubMed]

0305-7372

https://doi.org/10.1016/j.clbc.2015.02.005

46.

Murphy

CT

,

Li

T

,

Wang

LS

,

Obeid

EI

,

Bleicher

RJ

,

Eastwick

G

, et al.

Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery

.

Clin Breast Cancer

.

2015

Oct

;

15

(

5

):

381

–

9

.

[PubMed]

1526-8209

https://doi.org/10.1016/j.ejca.2015.04.018

47.

Martelli

G

,

Boracchi

P

,

Guzzetti

E

,

Marano

G

,

Lozza

L

,

Agresti

R

, et al.

Omission of radiotherapy in elderly patients with early breast cancer: 15-Year results of a prospective non-randomised trial

.

Eur J Cancer

.

2015

Jul

;

51

(

11

):

1358

–

64

.

[PubMed]

0959-8049

https://doi.org/10.1002/cncr.29377

48.

Rutter

CE

,

Lester-Coll

NH

,

Mancini

BR

,

Corso

CD

,

Park

HS

,

Yeboa

DN

, et al.

The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer

.

Cancer

.

2015

Jul

;

121

(

14

):

2331

–

40

.

[PubMed]

0008-543X

https://doi.org/10.1245/s10434-016-5368-z

49.

Mamtani

A

,

Gonzalez

JJ

,

Neo

D

,

Slanetz

PJ

,

Houlihan

MJ

,

Herold

CI

, et al.

Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes

.

Ann Surg Oncol

.

2016

Oct

;

23

(

10

):

3371

–

8

.

[PubMed]

1068-9265

https://doi.org/10.1002/cncr.28937

50.

Palta

M

,

Palta

P

,

Bhavsar

NA

,

Horton

JK

,

Blitzblau

RC

.

The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343

.

Cancer

.

2015

Jan

;

121

(

2

):

188

–

93

.

[PubMed]

0008-543X

https://doi.org/10.1016/j.clbc.2016.05.011

51.

Algan

O

,

Zhao

YD

,

Herman

T

.

Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer

.

Clin Breast Cancer

.

2016

Aug

;

16

(

4

):

e99

–

106

.

[PubMed]

1526-8209

https://doi.org/10.1200/JCO.2012.45.2615

52.

Hughes

KS

,

Schnaper

LA

,

Bellon

JR

,

Cirrincione

CT

,

Berry

DA

,

McCormick

B

, et al.

Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343

.

J Clin Oncol

.

2013

Jul

;

31

(

19

):

2382

–

7

.

[PubMed]

0732-183X

https://doi.org/10.1016/j.radonc.2017.02.019

53.

Chesney

TR

,

Yin

JX

,

Rajaee

N

,

Tricco

AC

,

Fyles

AW

,

Acuna

SA

, et al.

Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis

.

Radiother Oncol

.

2017

Apr

;

123

(

1

):

1

–

9

.

[PubMed]

0167-8140

https://doi.org/10.1016/S1470-2045(14)71221-5

54.

Kunkler

IH

,

Williams

LJ

,

Jack

WJ

,

Cameron

DA

,

Dixon

JM

;

PRIME II investigators

.

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

.

Lancet Oncol

.

2015

Mar

;

16

(

3

):

266

–

73

.

[PubMed]

1470-2045

https://doi.org/10.1186/s13014-017-0796-x

55.

Matuschek

C

,

Bölke

E

,

Haussmann

J

,

Mohrmann

S

,

Nestle-Krämling

C

,

Gerber

PA

, et al.

The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials

.

Radiat Oncol

.

2017

Mar

;

12

(

1

):

60

.

[PubMed]

1748-717X

https://doi.org/10.1016/j.clbc.2016.06.017

56.

Daugherty

EC

,

Daugherty

MR

,

Bogart

JA

,

Shapiro

A

.

Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer

.

Clin Breast Cancer

.

2016

Dec

;

16

(

6

):

500

–

506.e2

.

[PubMed]

1526-8209

https://doi.org/10.1016/j.ijsu.2016.05.046

57.

Esposito

E

,

Compagna

R

,

Rinaldo

M

,

Falivene

S

,

Ravo

V

,

Amato

B

, et al.

Intraoperative radiotherapy in elderly patients with breast cancer: is there a clinical applicability? Review of the current evidence

.

Int J Surg

.

2016

Sep

;

33

Suppl 1

:

S88

–

91

.

[PubMed]

1743-9191

https://doi.org/10.1016/S0140-6736(17)31145-5

58.

Coles

CE

,

Griffin

CL

,

Kirby

AM

,

Titley

J

,

Agrawal

RK

,

Alhasso

A

, et al.;

IMPORT Trialists

.

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

.

Lancet

.

2017

Sep

;

390

(

10099

):

1048

–

60

.

[PubMed]

0140-6736

https://doi.org/10.1016/S0140-6736(19)32515-2

59.

Whelan

TJ

,

Julian

JA

,

Berrang

TS

,

Kim

DH

,

Germain

I

,

Nichol

AM

, et al.;

RAPID Trial Investigators

.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

.

Lancet

.

2019

Dec

;

394

(

10215

):

2165

–

72

.

[PubMed]

0140-6736

https://doi.org/10.1016/S1470-2045(18)30195-5

60.

Schäfer

R

,

Strnad

V

,

Polgár

C

,

Uter

W

,

Hildebrandt

G

,

Ott

OJ

, et al.;

Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO)

.

Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial

.

Lancet Oncol

.

2018

Jun

;

19

(

6

):

834

–

44

.

[PubMed]

1470-2045

https://doi.org/10.1016/S0140-6736(15)00471-7

61.

Strnad

V

,

Ott

OJ

,

Hildebrandt

G

,

Kauer-Dorner

D

,

Knauerhase

H

,

Major

T

, et al.;

Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO)

.

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial

.

Lancet

.

2016

Jan

;

387

(

10015

):

229

–

38

.

[PubMed]

0140-6736

https://doi.org/10.1186/s13014-018-1119-6

62.

Kinj

R

,

Chand

ME

,

Gal

J

,

Gautier

M

,

Montagné

L

,

Lam Cham Kee

D

, et al.

Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome

.

Radiat Oncol

.

2018

Sep

;

13

(

1

):

174

.

[PubMed]

1748-717X

https://doi.org/10.1016/j.ijrobp.2008.11.005

63.

Kirova

YM

,

Campana

F

,

Savignoni

A

,

Laki

F

,

Muresan

M

,

Dendale

R

, et al.;

Institut Curie Breast Cancer Study Group

.

Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy

.

Int J Radiat Oncol Biol Phys

.

2009

Sep

;

75

(

1

):

76

–

81

.

[PubMed]

0360-3016

https://doi.org/10.1186/s13014-015-0448-y

64.

Doré

M

,

Cutuli

B

,

Cellier

P

,

Campion

L

,

Le Blanc

M

.

Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : analysis of 205 cases

.

Radiat Oncol

.

2015

Aug

;

10

(

1

):

161

.

[PubMed]

1748-717X

https://doi.org/10.1016/j.ijsu.2016.05.045

65.

Giugliano

FM

,

Falivene

S

,

Esposito

E

,

Di Franco

R

,

D’Aiuto

M

,

Lanza

F

, et al.

Short-course radiotherapy in elderly women with breast cancer: comparison by age, comorbidity index and toxicity

.

Int J Surg

.

2016

Sep

;

33

Suppl 1

:

S92

–

6

.

[PubMed]

1743-9191

https://doi.org/10.1111/tbj.13372

66.

Reboucas

LM

,

Campos

CS

,

D’Amico

GM

,

Lustosa

AB

,

Fregnani

JH

.

Once-weekly hypofractionated radiotherapy for breast cancer: first results of a phase II clinical trial

.

Breast J

.

2019

Sep

;

25

(

5

):

953

–

7

.

[PubMed]

1075-122X

https://doi.org/10.1016/j.ijrobp.2017.01.229

67.

Monten

C

,

Lievens

Y

,

Olteanu

LA

,

Paelinck

L

,

Speleers

B

,

Deseyne

P

, et al.

Highly Accelerated Irradiation in 5 Fractions (HAI-5): Feasibility in Elderly Women With Early or Locally Advanced Breast Cancer

.

Int J Radiat Oncol Biol Phys

.

2017

Jul

;

98

(

4

):

922

–

30

.

[PubMed]

0360-3016

https://doi.org/10.1080/07357907.2016.1182184

68.

Königsberg

R

,

Pfeiler

G

,

Hammerschmid

N

,

Holub

O

,

Glössmann

K

,

Larcher-Senn

J

, et al.

Breast cancer subtypes in patients aged 70 years and older

.

Cancer Invest

.

2016

May

;

34

(

5

):

197

–

204

.

[PubMed]

0735-7907

https://doi.org/10.1007/s00432-016-2194-4

69.

Wallwiener

CW

,

Hartkopf

AD

,

Grabe

E

,

Wallwiener

M

,

Taran

FA

,

Fehm

T

, et al.

Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

J Cancer Res Clin Oncol

.

2016

Aug

;

142

(

8

):

1847

–

53

.

[PubMed]

0171-5216

https://doi.org/10.1016/j.clbc.2016.04.001

70.

Hamelinck

VC

,

Bastiaannet

E

,

Pieterse

AH

,

de Glas

NA

,

Portielje

JE

,

Merkus

JW

, et al.

A Prospective Comparison of Younger and Older Patients’ Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer

.

Clin Breast Cancer

.

2016

Oct

;

16

(

5

):

379

–

88

.

[PubMed]

1526-8209

https://doi.org/10.1016/j.ctrv.2014.12.010

71.

Puts

MT

,

Tapscott

B

,

Fitch

M

,

Howell

D

,

Monette

J

,

Wan-Chow-Wah

D

, et al.

A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment

.

Cancer Treat Rev

.

2015

Feb

;

41

(

2

):

197

–

215

.

[PubMed]

0305-7372

https://doi.org/10.18632/oncotarget.8796

72.

Brouwers

B

,

Hatse

S

,

Dal Lago

L

,

Neven

P

,

Vuylsteke

P

,

Dalmasso

B

, et al.

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters

.

Oncotarget

.

2016

May

;

7

(

21

):

29977

–

88

.

[PubMed]

1949-2553

https://doi.org/10.1016/j.ejon.2016.12.007

73.

Oh

PJ

.

Predictors of cognitive decline in people with cancer undergoing chemotherapy

.

Eur J Oncol Nurs

.

2017

Apr

;

27

:

53

–

9

.

[PubMed]

1462-3889

https://doi.org/10.1200/JCO.19.00647

74.

Muss

HB

,

Polley

MC

,

Berry

DA

,

Liu

H

,

Cirrincione

CT

,

Theodoulou

M

, et al.

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

.

J Clin Oncol

.

2019

Sep

;

37

(

26

):

2338

–

48

.

[PubMed]

0732-183X

Available from: https://ascopost.com/issues/january-25-2015/no-benefit-for-adjuvant-capecitabine-monotherapy-in-elderly-patients-with-early-stage-breast-cancer/

75.

von Minckwitz

G

,

Reimer

T

,

Potenberg

J

,

Conrad

B

,

Schürer

U

,

Eidtmann

H

, et al. Abstract S3-04: The phase III ICE study: Adjuvant Ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer. General Session Abstracts. American Association for Cancer Research;

2015

; pp S3-04-S3-04.

76.

Wilmot

F

. SABCS 2014: ICE Study – Ibandronate with or without Capecitabine in Elderly Patients [Internet].

2015

Available from: https://bcaction.org/2015/01/23/sabcs-2014-ice-study-ibandronate-with-or-without-capecitabine-in-elderly-patients/

77.

Goodman

A

. No Benefit for Adjuvant Capecitabine Monotherapy in Elderly Patients With Early-Stage Breast Cancer [Internet].

2015

78.

Aapro

M

,

Tjulandin

S

,

Bhar

P

,

Gradishar

W

.

Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: a post-hoc analysis

.

Breast

.

2011

Oct

;

20

(

5

):

468

–

74

.

https://doi.org/10.1016/j.breast.2011.07.005

[PubMed]

0960-9776

https://doi.org/10.1002/cncr.29506

79.

von Minckwitz

G

,

Conrad

B

,

Reimer

T

,

Decker

T

,

Eidtmann

H

,

Eiermann

W

, et al.;

German Breast Group Investigators

.

A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)

.

Cancer

.

2015

Oct

;

121

(

20

):

3639

–

48

.

[PubMed]

0008-543X

https://doi.org/10.1200/JCO.2008.18.4028

80.

Jones

S

,

Holmes

FA

,

O’Shaughnessy

J

,

Blum

JL

,

Vukelja

SJ

,

McIntyre

KJ

, et al.

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

.

J Clin Oncol

.

2009

Mar

;

27

(

8

):

1177

–

83

.

[PubMed]

0732-183X

https://doi.org/10.1093/annonc/mdu564

81.

Perrone

F

,

Nuzzo

F

,

Di Rella

F

,

Gravina

A

,

Iodice

G

,

Labonia

V

, et al.

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial

.

Ann Oncol

.

2015

Apr

;

26

(

4

):

675

–

82

.

[PubMed]

0923-7534

https://doi.org/10.1200/JCO.2006.10.4976

82.

Pinder

MC

,

Duan

Z

,

Goodwin

JS

,

Hortobagyi

GN

,

Giordano

SH

.

Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer

.

J Clin Oncol

.

2007

Sep

;

25

(

25

):

3808

–

15

.

[PubMed]

0732-183X

https://doi.org/10.1016/j.critrevonc.2011.04.001

83.

Freyer

G

,

Campone

M

,

Peron

J

,

Facchini

T

,

Terret

C

,

Berdah

JF

, et al.

Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study

.

Crit Rev Oncol Hematol

.

2011

Dec

;

80

(

3

):

466

–

73

.

[PubMed]

1040-8428

https://doi.org/10.1200/JCO.2005.02.3028

84.

Giordano

SH

,

Duan

Z

,

Kuo

YF

,

Hortobagyi

GN

,

Goodwin

JS

.

Use and outcomes of adjuvant chemotherapy in older women with breast cancer

.

J Clin Oncol

.

2006

Jun

;

24

(

18

):

2750

–

6

.

[PubMed]

0732-183X

https://doi.org/10.1200/JCO.2005.03.6053

85.

Elkin

EB

,

Hurria

A

,

Mitra

N

,

Schrag

D

,

Panageas

KS

.

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort

.

J Clin Oncol

.

2006

Jun

;

24

(

18

):

2757

–

64

.

[PubMed]

0732-183X

https://doi.org/10.1200/JCO.2000.18.7.1412

86.

Crivellari

D

,

Bonetti

M

,

Castiglione-Gertsch

M

,

Gelber

RD

,

Rudenstam

CM

,

Thürlimann

B

, et al.

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII

.

J Clin Oncol

.

2000

Apr

;

18

(

7

):

1412

–

22

.

[PubMed]

0732-183X

https://doi.org/10.1200/JCO.1997.15.6.2302

87.

Pritchard

KI

,

Paterson

AH

,

Fine

S

,

Paul

NA

,

Zee

B

,

Shepherd

LE

, et al.;

Breast Cancer Site Group

.

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group

.

J Clin Oncol

.

1997

Jun

;

15

(

6

):

2302

–

11

.

[PubMed]

0732-183X

https://doi.org/10.1200/JCO.2004.02.145

88.

Fargeot

P

,

Bonneterre

J

,

Roché

H

,

Lortholary

A

,

Campone

M

,

Van Praagh

I

, et al.

Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial

.

J Clin Oncol

.

2004

Dec

;

22

(

23

):

4622

–

30

.

[PubMed]

0732-183X

https://doi.org/10.1001/jamaoncol.2020.2388

89.

Tamirisa

N

,

Lin

H

,

Shen

Y

,

Shaitelman

SF

,

Sri Karuturi

M

,

Giordano

SH

, et al.

Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer

.

JAMA Oncol

.

2020

Oct

;

6

(

10

):

1548

–

54

.

[PubMed]

2374-2437

https://doi.org/10.1007/s10549-016-4074-7

90.

Li

S

,

Liu

J

,

Virnig

BA

,

Collins

AJ

.

Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer

.

Breast Cancer Res Treat

.

2017

Feb

;

161

(

3

):

515

–

24

.

[PubMed]

0167-6806

https://doi.org/10.1200/JCO.2015.62.6341

91.

Lichtman

SM

,

Cirrincione

CT

,

Hurria

A

,

Jatoi

A

,

Theodoulou

M

,

Wolff

AC

, et al.

Effect of pretreatment renal function on treatment and clinical outcomes in the adjuvant treatment of older women with breast cancer: alliance A171201, an ancillary study of CALGB/CTSU 49907

.

J Clin Oncol

.

2016

Mar

;

34

(

7

):

699

–

705

.

[PubMed]

0732-183X

https://doi.org/10.1038/bjc.2016.360

92.

Sun

J

,

Chia

S

.

Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly

.

Br J Cancer

.

2017

Jan

;

116

(

1

):

4

–

9

.

[PubMed]

0007-0920

https://doi.org/10.1056/NEJMoa052306

93.

Piccart-Gebhart

MJ

,

Procter

M

,

Leyland-Jones

B

,

Goldhirsch

A

,

Untch

M

,

Smith

I

, et al.;

Herceptin Adjuvant (HERA) Trial Study Team

.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

.

N Engl J Med

.

2005

Oct

;

353

(

16

):

1659

–

72

.

[PubMed]

0028-4793

https://doi.org/10.1016/j.jacc.2012.07.068

94.

Chen

J

,

Long

JB

,

Hurria

A

,

Owusu

C

,

Steingart

RM

,

Gross

CP

.

Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer

.

J Am Coll Cardiol

.

2012

Dec

;

60

(

24

):

2504

–

12

.

[PubMed]

0735-1097

https://doi.org/10.1200/JCO.2013.48.7884

95.

Chavez-MacGregor

M

,

Zhang

N

,

Buchholz

TA

,

Zhang

Y

,

Niu

J

,

Elting

L

, et al.

Trastuzumab-related cardiotoxicity among older patients with breast cancer

.

J Clin Oncol

.

2013

Nov

;

31

(

33

):

4222

–

8

.

[PubMed]

0732-183X

https://doi.org/10.1200/JCO.2016.71.4345

96.

Reeder-Hayes

KE

,

Meyer

AM

,

Hinton

SP

,

Meng

K

,

Carey

LA

,

Dusetzina

SB

.

Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer

.

J Clin Oncol

.

2017

Oct

;

35

(

29

):

3298

–

305

.

[PubMed]

0732-183X

https://doi.org/10.1056/NEJMoa1406281

97.

Tolaney

SM

,

Barry

WT

,

Dang

CT

,

Yardley

DA

,

Moy

B

,

Marcom

PK

, et al.

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer

.

N Engl J Med

.

2015

Jan

;

372

(

2

):

134

–

41

.

[PubMed]

0028-4793

https://doi.org/10.1016/j.jgo.2015.06.003

98.

Sawaki

M

,

Taira

N

,

Uemura

Y

,

Saito

T

,

Baba

S

,

Kobayashi

K

, et al. Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients. J Clin Oncol.

2020

Sep

;JCO.20.00184.

99.

Dall

P

,

Lenzen

G

,

Göhler

T

,

Lerchenmüller

C

,

Feisel-Schwickardi

G

,

Koch

T

, et al.

Trastuzumab in the treatment of elderly patients with early breast cancer: results from an observational study in Germany

.

J Geriatr Oncol

.

2015

Nov

;

6

(

6

):

462

–

9

.

[PubMed]

1879-4068

https://doi.org/10.1200/JCO.19.00882

100.

Hurvitz

SA

,

Martin

M

,

Jung

KH

,

Huang

CS

,

Harbeck

N

,

Valero

V

, et al.

Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study

.

J Clin Oncol

.

2019

Sep

;

37

(

25

):

2206

–

16

.

[PubMed]

0732-183X

Available from: https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/adjuvant-ado-trastuzumab-emtansine-vs-paclitaxel-plus-trastuzumab-in-early-her2-positive-breast-cancer/

101.

Sara

M

. Tolaney, MD M. Adjuvant Ado-Trastuzumab Emtansine vs Paclitaxel Plus Trastuzumab in Early HER2-Positive Breast Cancer [Internet].

2020

102.

Runowicz

CD

,

Leach

CR

,

Henry

NL

,

Henry

KS

,

Mackey

HT

,

Cowens-Alvarado

RL

, et al.

American cancer society/American society of clinical oncology breast cancer survivorship care guideline

.

J Clin Oncol

.

2016

Feb

;

34

(

6

):

611

–

35

.

https://doi.org/10.1200/JCO.2015.64.3809

[PubMed]

0732-183X

https://doi.org/10.1001/jamaoncol.2016.3931

103.

Freedman

RA

,

Keating

NL

,

Partridge

AH

,

Muss

HB

,

Hurria

A

,

Winer

EP

.

Surveillance mammography in older patients with breast cancer-can we ever stop? a review

.

JAMA Oncol

.

2017

Mar

;

3

(

3

):

402

–

9

.

[PubMed]

2374-2437

https://doi.org/10.1200/JCO.2014.55.5409

104.

Ramsey

SD

,

Henry

NL

,

Gralow

JR

,

Mirick

DK

,

Barlow

W

,

Etzioni

R

, et al.

Tumor marker usage and medical care costs among older early-stage breast cancer survivors

.

J Clin Oncol

.

2015

Jan

;

33

(

2

):

149

–

55

.

[PubMed]

0732-183X

105.

Howlader

N

,

Noone

AM

,

Krapcho

M

,

Garshell

J

,

Miller

D

,

Altekruse

SF

, et al.

SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Based on November 2013 SEER data submission, posted to the SEER web site, April 2014

.

Seercancergov/Csr

;

2014

.

https://doi.org/10.1016/j.ejso.2017.01.014

106.

Kiderlen

M

,

van de Velde

CJ

,

Liefers

GJ

,

Bastiaannet

E

,

de Craen

AJ

,

Kuppen

PJ

, et al.;

FOCUS study group

.

Targeted therapy in older women with breast cancer - What’s the target?

Eur J Surg Oncol

.

2017

May

;

43

(

5

):

944

–

8

.

[PubMed]

0748-7983

https://doi.org/10.1016/j.molonc.2015.11.002

107.

Engels

CC

,

Kiderlen

M

,

Bastiaannet

E

,

Mooyaart

AL

,

van Vlierberghe

R

,

Smit

VT

, et al.

The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis

.

Mol Oncol

.

2016

Apr

;

10

(

4

):

594

–

600

.

[PubMed]

1574-7891

https://doi.org/10.1007/s10549-017-4282-9

108.

Gernaat

SA

,

Ho

PJ

,

Rijnberg

N

,

Emaus

MJ

,

Baak

LM

,

Hartman

M

, et al.

Risk of death from cardiovascular disease following breast cancer: a systematic review

.

Breast Cancer Res Treat

.

2017

Aug

;

164

(

3

):

537

–

55

.

[PubMed]

0167-6806